概要
創薬AI市場について調査・分析を行った市場レポート。創薬AIの市場規模、市場成長率、成長ドライバーや事業機会の分析に加えて、この市場における主要企業・プレイヤーや、シェアあるいは競争環境についての考察を、定量的データを交えて提供。分析は、オファリング別、プロセス別、ドラッグデザイン別、ドライ・ラボ別、ウェットラボ別、地域別の観点から、体系的に行われている。 ※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
Description
Table of Contents
Figures
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD TABLE 2 FACTOR ANALYSIS TABLE 3 RISK ASSESSMENT: AI IN DRUG DISCOVERY MARKET TABLE 4 GLOBAL INFLATION RATE PROJECTIONS, 2021-2027 (% GROWTH) TABLE 5 US HEALTH EXPENDITURE, 2019-2022 (USD MILLION) TABLE 6 US HEALTH EXPENDITURE, 2023-2027 (USD MILLION) TABLE 7 AI IN DRUG DISCOVERY MARKET: IMPACT ANALYSIS TABLE 8 INDICATIVE LIST OF COLLABORATIONS AND PARTNERSHIPS (2021-2023) TABLE 9 INDICATIVE LIST OF DRUGS LOSING PATENTS IN 2023 TABLE 10 AI IN DRUG DISCOVERY MARKET: PORTER’S FIVE FORCES ANALYSIS TABLE 11 AI IN DRUG DISCOVERY MARKET: INDICATIVE PRICING, BY PROCESS TABLE 12 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS TABLE 13 LIST OF PATENTS/PATENT APPLICATIONS IN AI IN DRUG DISCOVERY MARKET, 2021-2023 TABLE 14 KEY AI-DERIVED CLINICAL ASSETS, BY COMPANY TABLE 15 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2021-2028 (USD MILLION) TABLE 16 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR SERVICES, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 17 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR SOFTWARE, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 18 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 19 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR MACHINE LEARNING, BY TYPE, 2021-2028 (USD MILLION) TABLE 20 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR MACHINE LEARNING, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 21 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR DEEP LEARNING, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 22 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR SUPERVISED LEARNING, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 23 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR REINFORCEMENT LEARNING, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 24 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR UNSUPERVISED LEARNING, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 25 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR OTHER MACHINE LEARNING TECHNOLOGIES, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 26 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR NATURAL LANGUAGE PROCESSING, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 27 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR CONTEXT-AWARE PROCESSING & CONTEXT-AWARE COMPUTING, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 28 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 29 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION) TABLE 30 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR ONCOLOGY, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 31 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 32 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR NEUROLOGY, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 33 INDICATIVE LIST OF DEVELOPMENTS IN CARDIOVASCULAR DRUG DEVELOPMENT TABLE 34 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 35 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR IMMUNOLOGY, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 36 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 37 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 38 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY PROCESS, 2021-2028 (USD MILLION) TABLE 39 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR TARGET IDENTIFICATION & SELECTION, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 40 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR TARGET VALIDATION, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 41 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR HIT IDENTIFICATION & PRIORITIZATION, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 42 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR HIT-TO-LEAD IDENTIFICATION/LEAD GENERATION, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 43 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR LEAD OPTIMIZATION, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 44 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR CANDIDATE SELECTION & VALIDATION, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 45 AI IN DRUG DISCOVERY MARKET, BY USE CASE, 2021-2028 (USD MILLION) TABLE 46 AI IN DRUG DISCOVERY MARKET FOR SMALL-MOLECULE DESIGN & OPTIMIZATION, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 47 AI IN DRUG DISCOVERY MARKET FOR UNDERSTANDING DISEASE, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 48 AI IN DRUG DISCOVERY MARKET FOR SAFETY & TOXICITY, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 49 AI IN DRUG DISCOVERY MARKET FOR VACCINE DESIGN & OPTIMIZATION, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 50 AI IN DRUG DISCOVERY MARKET FOR ANTIBODY & OTHER BIOLOGIC DESIGN & OPTIMIZATION, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 51 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 52 INDICATIVE LIST OF DEVELOPMENTS RELATED TO AI IN PHARMACEUTICAL & BIOTECHNOLOGY INDUSTRY TABLE 53 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 54 INDICATIVE LIST OF COLLABORATIONS WITH CROS TABLE 55 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 56 INDICATIVE LIST OF RESEARCH COLLABORATIONS TABLE 57 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 58 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 59 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 60 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2021-2028 (USD MILLION) TABLE 61 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 62 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR MACHINE LEARNING, BY TYPE, 2021-2028 (USD MILLION) TABLE 63 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION) TABLE 64 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY PROCESS, 2021-2028 (USD MILLION) TABLE 65 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY USE CASE, 2021-2028 (USD MILLION) TABLE 66 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 67 US: INDICATIVE LIST OF STRATEGIC DEVELOPMENTS TABLE 68 US: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2021-2028 (USD MILLION) TABLE 69 US: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 70 US: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR MACHINE LEARNING, BY TYPE, 2021-2028 (USD MILLION) TABLE 71 US: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA 2021-2028 (USD MILLION) TABLE 72 US: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY PROCESS 2021-2028 (USD MILLION) TABLE 73 US: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY USE CASE, 2021-2028 (USD MILLION) TABLE 74 US: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 75 CANADA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2021-2028 (USD MILLION) TABLE 76 CANADA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 77 CANADA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR MACHINE LEARNING, BY TYPE, 2021-2028 (USD MILLION) TABLE 78 CANADA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION) TABLE 79 CANADA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY PROCESS, 2021-2028 (USD MILLION) TABLE 80 CANADA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY USE CASE, 2021-2028 (USD MILLION) TABLE 81 CANADA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 82 MEXICO: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2021-2028 (USD MILLION) TABLE 83 MEXICO: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 84 MEXICO: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR MACHINE LEARNING, BY TYPE, 2021-2028 (USD MILLION) TABLE 85 MEXICO: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION) TABLE 86 MEXICO: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY PROCESS, 2021-2028 (USD MILLION) TABLE 87 MEXICO: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY USE CASE, 2021-2028 (USD MILLION) TABLE 88 MEXICO: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 89 EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 90 EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2021-2028 (USD MILLION) TABLE 91 EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 92 EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR MACHINE LEARNING, BY TYPE, 2021-2028 (USD MILLION) TABLE 93 EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION) TABLE 94 EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY PROCESS, 2021-2028 (USD MILLION) TABLE 95 EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY USE CASE, 2021-2028 (USD MILLION) TABLE 96 EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 97 UK: INDICATIVE LIST OF STRATEGIC DEVELOPMENTS TABLE 98 UK: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2021-2028 (USD MILLION) TABLE 99 UK: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 100 UK: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR MACHINE LEARNING, BY TYPE, 2021-2028 (USD MILLION) TABLE 101 UK: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION) TABLE 102 UK: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY PROCESS, 2021-2028 (USD MILLION) TABLE 103 UK: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY USE CASE, 2021-2028 (USD MILLION) TABLE 104 UK: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 105 GERMANY: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2021-2028 (USD MILLION) TABLE 106 GERMANY: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 107 GERMANY: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR MACHINE LEARNING, BY TYPE, 2021-2028 (USD MILLION) TABLE 108 GERMANY: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION) TABLE 109 GERMANY: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY PROCESS, 2021-2028 (USD MILLION) TABLE 110 GERMANY: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY USE CASE, 2021-2028 (USD MILLION) TABLE 111 GERMANY: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 112 FRANCE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2021-2028 (USD MILLION) TABLE 113 FRANCE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 114 FRANCE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR MACHINE LEARNING, BY TYPE, 2021-2028 (USD MILLION) TABLE 115 FRANCE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION) TABLE 116 FRANCE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY PROCESS, 2021-2028 (USD MILLION) TABLE 117 FRANCE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY USE CASE, 2021-2028 (USD MILLION) TABLE 118 FRANCE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 119 ITALY: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2021-2028 (USD MILLION) TABLE 120 ITALY: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 121 ITALY: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR MACHINE LEARNING, BY TYPE, 2021-2028 (USD MILLION) TABLE 122 ITALY: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION) TABLE 123 ITALY: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY PROCESS, 2021-2028 (USD MILLION) TABLE 124 ITALY: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY USE CASE, 2021-2028 (USD MILLION) TABLE 125 ITALY: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 126 REST OF EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2021-2028 (USD MILLION) TABLE 127 REST OF EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 128 REST OF EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR MACHINE LEARNING, BY TYPE, 2021-2028 (USD MILLION) TABLE 129 REST OF EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION) TABLE 130 REST OF EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY PROCESS, 2021-2028 (USD MILLION) TABLE 131 REST OF EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY USE CASE, 2021-2028 (USD MILLION) TABLE 132 REST OF EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 133 ASIA PACIFIC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 134 ASIA PACIFIC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2021-2028 (USD MILLION) TABLE 135 ASIA PACIFIC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 136 ASIA PACIFIC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR MACHINE LEARNING, BY TYPE, 2021-2028 (USD MILLION) TABLE 137 ASIA PACIFIC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION) TABLE 138 ASIA PACIFIC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY PROCESS, 2021-2028 (USD MILLION) TABLE 139 ASIA PACIFIC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY USE CASE, 2021-2028 (USD MILLION) TABLE 140 ASIA PACIFIC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 141 JAPAN: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2021-2028 (USD MILLION) TABLE 142 JAPAN: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 143 JAPAN: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR MACHINE LEARNING, BY TYPE, 2021-2028 (USD MILLION) TABLE 144 JAPAN: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION) TABLE 145 JAPAN: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY PROCESS, 2021-2028 (USD MILLION) TABLE 146 JAPAN: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY USE CASE, 2021-2028 (USD MILLION) TABLE 147 JAPAN: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 148 CHINA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2021-2028 (USD MILLION) TABLE 149 CHINA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 150 CHINA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR MACHINE LEARNING, BY TYPE, 2021-2028 (USD MILLION) TABLE 151 CHINA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION) TABLE 152 CHINA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY PROCESS, 2021-2028 (USD MILLION) TABLE 153 CHINA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY USE CASE, 2021-2028 (USD MILLION) TABLE 154 CHINA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 155 INDIA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2021-2028 (USD MILLION) TABLE 156 INDIA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 157 INDIA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR MACHINE LEARNING, BY TYPE, 2021-2028 (USD MILLION) TABLE 158 INDIA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION) TABLE 159 INDIA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY PROCESS, 2021-2028 (USD MILLION) TABLE 160 INDIA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY USE CASE, 2021-2028 (USD MILLION) TABLE 161 INDIA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 162 REST OF ASIA PACIFIC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2021-2028 (USD MILLION) TABLE 163 REST OF ASIA PACIFIC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 164 REST OF ASIA PACIFIC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR MACHINE LEARNING, BY TYPE, 2021-2028 (USD MILLION) TABLE 165 REST OF ASIA PACIFIC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION) TABLE 166 REST OF ASIA PACIFIC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY PROCESS, 2021-2028 (USD MILLION) TABLE 167 REST OF ASIA PACIFIC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY USE CASE, 2021-2028 (USD MILLION) TABLE 168 REST OF ASIA PACIFIC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 169 SOUTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2021-2028 (USD MILLION) TABLE 170 SOUTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 171 SOUTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR MACHINE LEARNING, BY TYPE, 2021-2028 (USD MILLION) TABLE 172 SOUTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION) TABLE 173 SOUTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY PROCESS, 2021-2028 (USD MILLION) TABLE 174 SOUTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY USE CASE, 2021-2028 (USD MILLION) TABLE 175 SOUTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 176 MIDDLE EAST & AFRICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2021-2028 (USD MILLION) TABLE 177 MIDDLE EAST & AFRICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 178 MIDDLE EAST & AFRICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR MACHINE LEARNING, BY TYPE, 2021-2028 (USD MILLION) TABLE 179 MIDDLE EAST & AFRICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2021-2028 (USD MILLION) TABLE 180 MIDDLE EAST & AFRICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY PROCESS, 2021-2028 (USD MILLION) TABLE 181 MIDDLE EAST & AFRICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY USE CASE, 2021-2028 (USD MILLION) TABLE 182 MIDDLE EAST & AFRICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 183 OVERVIEW OF STRATEGIES ADOPTED BY KEY AI IN DRUG DISCOVERY PLAYERS, FEBRUARY 2021- MAY 2022 TABLE 184 AI IN DRUG DISCOVERY MARKET: DEGREE OF COMPETITION TABLE 185 USE CASE FOOTPRINT (24 COMPANIES) TABLE 186 PROCESS FOOTPRINT (24 COMPANIES) TABLE 187 REGION FOOTPRINT (24 COMPANIES) TABLE 188 COMPANY FOOTPRINT (24 COMPANIES) TABLE 189 AI IN DRUG DISCOVERY MARKET: DETAILED LIST OF KEY SMES/START-UPS TABLE 190 USE CASE FOOTPRINT (START-UPS/SMES) TABLE 191 PROCESS FOOTPRINT (START-UPS/SMES) TABLE 192 REGION FOOTPRINT (START-UPS/SMES) TABLE 193 COMPANY FOOTPRINT (START-UPS/SMES) TABLE 194 AI IN DRUG DISCOVERY MARKET: PRODUCT LAUNCHES & ENHANCEMENTS, 2021-2023 TABLE 195 AI IN DRUG DISCOVERY MARKET: DEALS, 2021-2023 TABLE 196 AI IN DRUG DISCOVERY MARKET: OTHER DEVELOPMENTS, 2021-2023 TABLE 197 NVIDIA CORPORATION: COMPANY OVERVIEW TABLE 198 NVIDIA CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED TABLE 199 NVIDIA CORPORATION: PRODUCT/SERVICE LAUNCHES TABLE 200 NVIDIA CORPORATION: DEALS TABLE 201 EXSCIENTIA: COMPANY OVERVIEW TABLE 202 EXSCIENTIA: PRODUCTS/SOLUTIONS/SERVICES OFFERED TABLE 203 EXSCIENTIA: PRODUCT/SERVICE LAUNCHES TABLE 204 EXSCIENTIA: DEALS TABLE 205 EXSCIENTIA: OTHER DEVELOPMENTS TABLE 206 GOOGLE: COMPANY OVERVIEW TABLE 207 GOOGLE: PRODUCTS/SOLUTIONS/SERVICES OFFERED TABLE 208 GOOGLE: PRODUCT/SERVICE LAUNCHES TABLE 209 GOOGLE: DEALS TABLE 210 GOOGLE: OTHER DEVELOPMENTS TABLE 211 BENEVOLENTAI: COMPANY OVERVIEW TABLE 212 BENEVOLENTAI: PRODUCTS/SOLUTIONS/SERVICES OFFERED TABLE 213 BENEVOLENTAI: DEALS TABLE 214 RECURSION: COMPANY OVERVIEW TABLE 215 RECURSION: PRODUCTS/SOLUTIONS/SERVICES OFFERED TABLE 216 RECURSION: PRODUCT/SERVICE LAUNCHES TABLE 217 RECURSION: DEALS TABLE 218 RECURSION: OTHER DEVELOPMENTS TABLE 219 INSILICO MEDICINE: COMPANY OVERVIEW TABLE 220 INSILICO MEDICINE: PRODUCTS/SOLUTIONS/SERVICES OFFERED TABLE 221 INSILICO MEDICINE: PRODUCT/SERVICE LAUNCHES TABLE 222 INSILICO MEDICINE: DEALS TABLE 223 INSILICO MEDICINE: OTHER DEVELOPMENTS TABLE 224 SCHRÖDINGER, INC.: COMPANY OVERVIEW TABLE 225 SCHRÖDINGER, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED TABLE 226 SCHRÖDINGER, INC.: DEALS TABLE 227 SCHRÖDINGER, INC.: OTHER DEVELOPMENTS TABLE 228 MICROSOFT CORPORATION: COMPANY OVERVIEW TABLE 229 MICROSOFT CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED TABLE 230 MICROSOFT CORPORATION: SERVICE LAUNCHES TABLE 231 MICROSOFT CORPORATION: DEALS TABLE 232 ATOMWISE INC.: COMPANY OVERVIEW TABLE 233 ATOMWISE INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED TABLE 234 ATOMWISE INC.: DEALS TABLE 235 ILLUMINA, INC.: COMPANY OVERVIEW TABLE 236 ILLUMINA, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED TABLE 237 ILLUMINA, INC.: PRODUCT/SERVICE LAUNCHES TABLE 238 ILLUMINA, INC.: DEALS TABLE 239 NUMEDII, INC.: COMPANY OVERVIEW TABLE 240 NUMEDII, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED TABLE 241 XTALPI INC.: COMPANY OVERVIEW TABLE 242 XTALPI INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED TABLE 243 XTALPI INC.: DEALS TABLE 244 IKTOS: COMPANY OVERVIEW TABLE 245 IKTOS: PRODUCTS/SOLUTIONS/SERVICES OFFERED TABLE 246 IKTOS: DEALS TABLE 247 IKTOS: OTHER DEVELOPMENTS TABLE 248 TEMPUS LABS: COMPANY OVERVIEW TABLE 249 TEMPUS LABS: PRODUCTS/SOLUTIONS/SERVICES OFFERED TABLE 250 TEMPUS LABS: PRODUCT/SERVICE LAUNCHES TABLE 251 TEMPUS LABS: DEALS TABLE 252 TEMPUS LABS: OTHER DEVELOPMENTS TABLE 253 DEEP GENOMICS, INC.: COMPANY OVERVIEW TABLE 254 DEEP GENOMICS, INC.: PRODUCTS/SERVICES OFFERED TABLE 255 DEEP GENOMICS, INC.: DEALS TABLE 256 DEEP GENOMICS, INC.: OTHER DEVELOPMENTS TABLE 257 VERGE GENOMICS: COMPANY OVERVIEW TABLE 258 VERGE GENOMICS: PRODUCTS/SERVICES OFFERED TABLE 259 VERGE GENOMICS: DEALS TABLE 260 BENCHSCI: COMPANY OVERVIEW TABLE 261 BENCHSCI: PRODUCTS/SOLUTIONS/SERVICES OFFERED TABLE 262 BENCHSCI: PRODUCT/SERVICE LAUNCHES TABLE 263 BENCHSCI: OTHER DEVELOPMENTS TABLE 264 INSITRO: COMPANY OVERVIEW TABLE 265 INSITRO: PRODUCTS/SOLUTIONS/SERVICES OFFERED TABLE 266 INSITRO: OTHER DEVELOPMENTS TABLE 267 VALO HEALTH: COMPANY OVERVIEW TABLE 268 VALO HEALTH: PRODUCTS/SOLUTIONS/SERVICES OFFERED TABLE 269 VALO HEALTH: DEALS TABLE 270 VALO HEALTH: OTHER DEVELOPMENTS TABLE 271 BPGBIO, INC.: COMPANY OVERVIEW TABLE 272 BPGBIO, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED TABLE 273 BPGBIO, INC.: DEALS
FIGURE 1 AI IN DRUG DISCOVERY MARKET: MARKET SEGMENTATION FIGURE 2 RESEARCH DESIGN FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY DEMAND SIDE FIGURE 4 SUPPLY-SIDE MARKET ESTIMATION: REVENUE SHARE ANALYSIS FIGURE 5 BOTTOM-UP APPROACH: END-USER SPENDING ON AI IN DRUG DISCOVERY FIGURE 6 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2022-2027) FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS FIGURE 8 TOP-DOWN APPROACH FIGURE 9 DATA TRIANGULATION METHODOLOGY FIGURE 10 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2023 VS. 2028 (USD MILLION) FIGURE 11 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION) FIGURE 12 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2023 VS. 2028 (USD MILLION) FIGURE 13 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY PROCESS FIGURE 14 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY USE CASE FIGURE 15 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) FIGURE 16 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET: GEOGRAPHICAL SNAPSHOT FIGURE 17 GROWING NUMBER OF CROSS-INDUSTRY COLLABORATIONS & PARTNERSHIPS TO DRIVE MARKET FIGURE 18 NORTH AMERICA TO DOMINATE AI IN DRUG DISCOVERY MARKET DURING FORECAST PERIOD FIGURE 19 US TO REGISTER HIGHEST REVENUE GROWTH FROM 2023 TO 2028 FIGURE 20 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND US HELD LARGEST SHARE IN NORTH AMERICA, 2022 FIGURE 21 SERVICES TO HOLD MAJORITY MARKET SHARE IN 2028 FIGURE 22 MACHINE LEARNING TO RETAIN MARKET LEADERSHIP TILL 2028 FIGURE 23 ONCOLOGY TO DOMINATE MARKET IN 2028 FIGURE 24 HIT-TO LEAD IDENTIFICATION/LEAD GENERATION TO DOMINATE MARKET IN 2028 FIGURE 25 SMALL MOLECULE DESIGN & OPTIMIZATION TO REGISTER HIGHEST GROWTH OVER FORECAST PERIOD FIGURE 26 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR LARGEST MARKET SHARE IN 2028 FIGURE 27 AI IN DRUG DISCOVERY: MARKET DYNAMICS FIGURE 28 EVOLUTION OF AI IN DRUG DISCOVERY MARKET FIGURE 29 STRUCTURE-BASED DRUG DESIGNING: AI IN DRUG DISCOVERY MARKET FIGURE 30 AI IN DRUG DISCOVERY MARKET: SUPPLY CHAIN ANALYSIS (2022) FIGURE 31 AI IN DRUG DISCOVERY MARKET ECOSYSTEM FIGURE 32 AI IN DRUG DISCOVERY MARKET: CLASSIFICATION FIGURE 33 AI IN LIFE SCIENCES: BUSINESS MODELS FIGURE 34 BENEFITS OF HYBRID BUSINESS MODELS FIGURE 35 SPECIALIZATION OF AI COMPANIES OVER TIME FIGURE 36 TOP PATENT OWNERS AND APPLICANTS FOR AI IN DRUG DISCOVERY SOLUTIONS (JANUARY 2011-OCTOBER 2023) FIGURE 37 AI IN DRUG DISCOVERY MARKET: PATENT ANALYSIS (JANUARY 2011-OCTOBER 2023) FIGURE 38 TOP APPLICANT COUNTRIES/REGIONS FOR AI IN DRUG DISCOVERY PATENTS (JANUARY 2012-JULY 2023) FIGURE 39 REVENUE SHIFT IN AI IN DRUG DISCOVERY MARKET FIGURE 40 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF AI IN DRUG DISCOVERY MARKET FIGURE 41 KEY BUYING CRITERIA FOR END USERS FIGURE 42 HIT-TO-LEAD IDENTIFICATION/LEAD GENERATION SEGMENT HELD LARGEST MARKET SHARE IN 2022 FIGURE 43 SMALL-MOLECULE DESIGN & OPTIMIZATION SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 FIGURE 44 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET SNAPSHOT FIGURE 45 DISTRIBUTION OF R&D COMPANIES, BY COUNTRY/REGION (2021 VS. 2022) FIGURE 46 REVENUE ANALYSIS OF TOP MARKET PLAYERS, 2022 FIGURE 47 AI IN DRUG DISCOVERY MARKET: MARKET SHARE ANALYSIS, 2022 FIGURE 48 AI IN DRUG DISCOVERY MARKET: COMPANY EVALUATION MATRIX, 2022 FIGURE 49 AI IN DRUG DISCOVERY MARKET: START-UP/SME EVALUATION MATRIX, 2022 FIGURE 50 NVIDIA CORPORATION: COMPANY SNAPSHOT, 2022 FIGURE 51 EXSCIENTIA: COMPANY SNAPSHOT (2022) FIGURE 52 GOOGLE: COMPANY SNAPSHOT (2022) FIGURE 53 BENEVOLENTAI: COMPANY SNAPSHOT (2022) FIGURE 54 RECURSION: COMPANY SNAPSHOT (2022) FIGURE 55 SCHRÖDINGER, INC.: COMPANY SNAPSHOT (2022) FIGURE 56 MICROSOFT CORPORATION: COMPANY SNAPSHOT (2023) FIGURE 57 ILLUMINA, INC.: COMPANY SNAPSHOT (2022)